Duke University School of Medicine

Milestone Pharmaceuticals to Host Investor and Analyst Webcast to Review Data from ReVeRA Phase 2 Study of Etripamil in AFib-RVR

Retrieved on: 
Tuesday, November 7, 2023
Milestone, Duke University School of Medicine, Revera, Science, Assistant, American Heart Association, MD, Atrial fibrillation, Cardiology, Clinical Cardiology, Conference, British Heart Foundation, Saint George, MBA, News, Baozou Big News Events, Webcast, University, Conference call, AHA, University of London, Patient, Pharmaceutical industry

Cardiac Electrophysiology Key Opinion Leaders joining the webcast include A. John Camm, MD, and Sean Pokorney, MD

Key Points: 
  • Cardiac Electrophysiology Key Opinion Leaders joining the webcast include A. John Camm, MD, and Sean Pokorney, MD
    Conference call and webcast on Monday, November 13, 2023 at 8:00 a.m.
  • ET
    MONTREAL and CHARLOTTE, N.C., Nov. 7, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that the Company will host a virtual investor and analyst webcast on Monday, November 13, 2023 at 8:00 a.m.
  • The webcast will focus on results from the ReVeRA Phase 2 study of investigational new drug etripamil in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR), which is being presented as a Featured Science presentation at the American Heart Association (AHA) Scientific Sessions 2023.
  • To access a live or recorded webcast of the event and accompanying slides, please visit the News & Events section of Milestone's investor relations website at investors.milestonepharma.com .

Research Funded by Bay Area Lyme Foundation Identifies New Investigational Therapy Regimen Capable of Irreversibly Damaging Lyme Bacteria in Laboratory Tests

Retrieved on: 
Wednesday, November 1, 2023
Linda, Knowledge, Lyme disease, University of California, Davis, Stanford University, Infection, UC, Obesity, MD, University of North Carolina, Doctor of Philosophy, Research, Light, Protein, Duke University School of Medicine, Borrelia burgdorferi, Medicine, Hypertension, Immunotherapy, Bacteria, University, Cell Chemical Biology, Cancer, Hsp90, Cell wall, Patient, Tulane University, DNA, Fatigue, Pharmaceutical industry, Vaccine, Pharmacology

“Bay Area Lyme concentrates on funding innovative research, including projects where knowledge can be deployed from other areas of medicine.

Key Points: 
  • “Bay Area Lyme concentrates on funding innovative research, including projects where knowledge can be deployed from other areas of medicine.
  • He encouraged scientists to take cancer staging techniques and immunotherapy learnings from oncology and apply them to Lyme research.
  • Bay Area Lyme Foundation also funded University of North Carolina collaborator, Matt Redinbo , PhD’s research on HS-291; his lab’s crystallography work was instrumental in the discovery process.
  • Bay Area Lyme Foundation’s research grant program was made possible by the support from the Fairbairn Family, the Younger Family Fund, and Project Lyme .

American Physical Therapy Association Announces New Editor-In-Chief of PTJ: Physical Therapy & Rehabilitation Journal

Retrieved on: 
Wednesday, November 1, 2023
Duke University School of Medicine, Duke University, Health, MPA, Department of Defense Instruction 1300.28, Doctor of Philosophy, Research, American Physical Therapy Association, Rehabilitation, Growth, Student, Therapy, PT, Bangladesh Technical Education Board, APTA, Oxford University Press, Pharmaceutical industry, Nursing, Orthopedic surgery, PTJ

ALEXANDRIA, Va., Nov. 1, 2023 /PRNewswire/ -- The American Physical Therapy Association announces the appointment of Steven Z. George, PT, PhD, FAPTA, as editor-in-chief of its flagship scientific journal, PTJ: Physical Therapy & Rehabilitation Journal.

Key Points: 
  • ALEXANDRIA, Va., Nov. 1, 2023 /PRNewswire/ -- The American Physical Therapy Association announces the appointment of Steven Z. George, PT, PhD, FAPTA, as editor-in-chief of its flagship scientific journal, PTJ: Physical Therapy & Rehabilitation Journal.
  • George and his collaborators have authored over 320 peer-reviewed publications in leading physical therapy, medical, orthopaedic, rehabilitation, and pain research journals.
  • His research has been funded by the National Institutes of Health, the Department of Defense, and the Academy of Orthopaedic Physical Therapy of the American Physical Therapy Association.
  • The American Physical Therapy Association represents more than 100,000 physical therapists, physical therapist assistants, and physical therapy students nationwide.

SciTech Development Announces The Formation of a Distinguished Medical Advisory Board With Top Oncology Specialists

Retrieved on: 
Thursday, October 26, 2023
FAAD, Laboratory, FDA, Columbia University Irving Medical Center, FARMS, SciTech, University of Washington School of Medicine, Duke University, Therapy, SDP, MD, Publication, Retinoid, Duke University School of Medicine, Bone marrow, Fenretinide, Division, Clinical trial, Internal medicine, MAB, Emory University, Malignancy, Bexarotene, University, Immediate, Safety, Cancer, International Society, Patient, Toxicity, Fred Hutchinson Cancer Research Center, Lymphoma, Vaccine, Pharmaceutical industry, Research, Dermatology, Medicine

GROSSE POINTE FARMS, Mich., Oct. 26, 2023 /PRNewswire/ -- SciTech Development, LLC, today announced the formation of a distinguished and independent medical advisory board (MAB) comprised of key opinion leaders and world-renowned experts in T-Cell Lymphomas and hematological malignancies.

Key Points: 
  • GROSSE POINTE FARMS, Mich., Oct. 26, 2023 /PRNewswire/ -- SciTech Development, LLC, today announced the formation of a distinguished and independent medical advisory board (MAB) comprised of key opinion leaders and world-renowned experts in T-Cell Lymphomas and hematological malignancies.
  • The board will provide strategic and clinical advice for SciTech's outreach and education initiatives within the oncology community.
  • The three medical advisors appointed to the board are Madeleine Duvic, M.D., Larisa Geskin, M.D., and Ajay Gopal, M.D.
  • Madeleine Duvic, MD – "The development of ST-100 is exciting because this new drug holds the promise of improved bioavailability, leading to increased efficacy with low toxicity."

Oncternal Therapeutics Adds Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board

Retrieved on: 
Wednesday, October 25, 2023
Trial of the century, Harvard Medical School, Brigham and Women's Hospital, Therapy, Clinical Cancer Research, Prostate cancer, MD, Dana–Farber Cancer Institute, Doctor of Philosophy, HIV disease progression rates, Journal, Internal medicine, Estate (law), Duke University School of Medicine, Abiraterone acetate, Metastasis, SAN, Oncology, Biochemistry, Massachusetts Institute of Technology, Journal of Clinical Oncology, AR, Canisius College, Patient, Hospital, SAB, Massachusetts Institute of Technology School of Engineering, Prostate, The New England Journal of Medicine, Pharmaceutical industry, Medicine, Lancet

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the addition of Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board (SAB).

Key Points: 
  • SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the addition of Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board (SAB).
  • “We wholeheartedly welcome Dr. Smith to Oncternal’s Prostate Cancer Scientific Advisory Board,” said James Breitmeyer, M.D., Ph.D., Oncternal’s President and CEO.
  • He has published extensively on the treatment and prevention of bone metastases, prostate cancer survivorship, and novel androgen receptor pathway inhibitors.
  • He completed a fellowship in Medical Oncology at Dana Farber Cancer Institute and a postdoctoral fellowship at Massachusetts Institute of Technology.

MacDermott Method Launches Groundbreaking 14-Day Parent/Teen Relationship Reset App

Retrieved on: 
Wednesday, October 25, 2023
National Guard, Marriage, Duke University School of Medicine, Colorado–Slovenia National Guard Partnership, BEACH, Mac Diarmada, Research, Administration, PALM, Edward Hines Jr. Veterans Administration Hospital, Curriculum, Parenting, School, Hospital, Navy, Veteran, Willie L. Williams, Communication, Bangladesh Technical Education Board, Parent, Toy, Tutoring

Developed by licensed marriage and family therapist Kristin MacDermott, this easy-to-use program gives parents a step-by-step process for resetting their relationships with their teens at that crucial time when many parent/teen relationships unravel.

Key Points: 
  • Developed by licensed marriage and family therapist Kristin MacDermott, this easy-to-use program gives parents a step-by-step process for resetting their relationships with their teens at that crucial time when many parent/teen relationships unravel.
  • "This 14-day program is the culmination of 20 years of research and development in resilience and relationships, and I am thrilled to make it available in an app, so parents can use it anywhere.
  • The 14-Day Parent/Teen Relationship Reset is the latest addition to MacDermott Method's portfolio of services and resources, which includes resilience-training programs for schools, coaches, and family advisors, reflecting their dedication to enhancing the lives of families and communities.
  • For more information about the MacDermott Method and the 14-Day Parent/Teen Relationship Reset Program, please visit our website .

Basilea reports new data for ceftobiprole (Zevtera®) presented at US IDWeek Congress 2023

Retrieved on: 
Tuesday, October 17, 2023
Efficacy, Staphylococcus, Methicillin-resistant Staphylococcus aureus, Ambrose, Abstract, Treatment, Clinical, Circulatory system, MRSA, Biomedical Advanced Research and Development Authority, BARDA, Enterococcus faecalis, Infection, ASPR, MSSA, IDSA, Isolates, Laboratory, Liolios Xirolivaditis, Staphylococcus aureus, PK/PD models, SAB, ABSSSI, CABP, Bronchopneumonia, Administration for Strategic Preparedness and Response, Streptococcus pneumoniae, Prescription Drug User Fee Act, Duke University School of Medicine, Infectious Diseases Society of America, Randomness, Development, Administration, Safety, Patient, PDUFA, HHS, Pharmaceutical industry, Vaccine, Ceftobiprole, Litherland, Enterococcus, Allschwil, Streptococcus, Bloodstream infections

Dr. Marc Engelhardt, Chief Medical Officer of Basilea, stated: “The data presented at IDWeek provide further evidence for the potent antimicrobial activity of ceftobiprole against MRSA and other clinically relevant pathogens.

Key Points: 
  • Dr. Marc Engelhardt, Chief Medical Officer of Basilea, stated: “The data presented at IDWeek provide further evidence for the potent antimicrobial activity of ceftobiprole against MRSA and other clinically relevant pathogens.
  • It also provides results of pharmacokinetic-pharmacodynamic modeling supporting the dosing regimens to treat severe bacterial infections from the successful clinical phase 3 studies.
  • Abstract #1946 – In Vitro Activity of Ceftobiprole against Staphylococcus aureus Bacteremia Isolates from the United States (2018–2020) – L. Duncan, M. Castanheira, J. I.
  • Smart, M. E. Jones, P. G. Ambrose, K. Litherland
    Abstract #2561 – Population Pharmacokinetic Analyses for Ceftobiprole Using Data from Phase 1 and 3 Studies – A. P. Cammarata, K. Litherland, M. C. Safir, S. M. Bhavnani, M. Saulay, J. I.

Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicated to its Genetic Medicine Delivery Platform

Retrieved on: 
Thursday, October 12, 2023
University of Pennsylvania, Knowledge, Doctor of Philosophy, Neuroscience, University of Massachusetts Chan Medical School, Education minister, CSO, Pediatrics, Stanford University School of Medicine, LDRI, Translational research, MD, Gene, United States Air Force Scientific Advisory Board, University, Duke University School of Medicine, Translation, Gene therapy, Université catholique de Louvain, Laboratory, AAV, Growth, Genetics, DSM-IV codes, DVM, LFCS, SAB, Patient, Vaccine, Management

Their collective expertise will also contribute to enhancing the ALIGATER™ platform and expanding its potential across viral (adeno-associated virus; AAV) and non-viral vector-based therapeutics, unlocking the potential to develop novel genetic medicines targeting serious diseases.

Key Points: 
  • Their collective expertise will also contribute to enhancing the ALIGATER™ platform and expanding its potential across viral (adeno-associated virus; AAV) and non-viral vector-based therapeutics, unlocking the potential to develop novel genetic medicines targeting serious diseases.
  • Lolita Petit, CSO of Coave Therapeutics commented, “We are absolutely thrilled to welcome our exceptional Scientific Advisory Board to the Coave team.
  • Each of these distinguished members has made profound contributions to the fields of genetic medicine, gene therapy, and neurosciences, bringing a unique depth of knowledge and experience to Coave.
  • We eagerly anticipate the opportunity to leverage their unique scientific insights to continue to advance our pipeline and ALIGATER platform.

Gallup Partners with Radiant Foundation on New Global Report on Spirituality as a Tool to Support Mental Health

Retrieved on: 
Monday, October 9, 2023
Civic, Workplace, Social Life, Inclusion, Community, Gallup, Emotion, Religion, Behavioural sciences, World Mental Health Day, Duke University School of Medicine, Mental health, Movement, Meta-analysis, Spirituality, Diversity, Digital Media Initiative, Psychiatry, Literature, Element, Optimism, Life, Research, Nursing

LONDON, Oct. 9, 2023 /PRNewswire/ -- On the eve World Mental Health Day, Radiant Foundation's Faith & Media Initiative partnered with Gallup to launch Faith and Wellness: The Worldwide Connection Between Spirituality & Wellbeing report (linked here), a meta-analysis of academic and Gallup global data that uncovers ways in which spirituality can help address the global mental health crisis. An analysis of World Poll data over ten years, over 140 countries, and approximately 1.47 million people interviewed, shows a strong association between religiosity and wellbeing. Gallup indexes that measure positive emotions, social life, optimism, and community engagement show a positive relationship between religiosity – defined by the importance of religion in one's daily life – and wellbeing outcomes.

Key Points: 
  • This more expansive measure will help us truly understand how factors of faith and spirituality can strengthen mental health.
  • An analysis of 2012-2022 Gallup World Poll data shows that spirituality and various wellbeing outcomes differ broadly at the global level.
  • The report also poses the question of how workplaces might incorporate elements of spirituality into employee wellbeing programs, given the U.S.
  • "Faith and spirituality need to be an integral part of any organization's Diversity, Equity, and Inclusion efforts."

Gallup Partners with Radiant Foundation on New Global Report on Spirituality as a Tool to Support Mental Health

Retrieved on: 
Monday, October 9, 2023
Civic, Workplace, Social Life, Inclusion, Community, Gallup, Emotion, Religion, Behavioural sciences, World Mental Health Day, Duke University School of Medicine, Mental health, Movement, Meta-analysis, Spirituality, Diversity, Digital Media Initiative, Psychiatry, Literature, Element, Optimism, Life, Research, Nursing

LONDON, Oct. 9, 2023 /PRNewswire/ -- On the eve World Mental Health Day, Radiant Foundation's Faith & Media Initiative partnered with Gallup to launch Faith and Wellness: The Worldwide Connection Between Spirituality & Wellbeing report (linked here), a meta-analysis of academic and Gallup global data that uncovers ways in which spirituality can help address the global mental health crisis. An analysis of World Poll data over ten years, over 140 countries, and approximately 1.47 million people interviewed, shows a strong association between religiosity and wellbeing. Gallup indexes that measure positive emotions, social life, optimism, and community engagement show a positive relationship between religiosity – defined by the importance of religion in one's daily life – and wellbeing outcomes.

Key Points: 
  • This more expansive measure will help us truly understand how factors of faith and spirituality can strengthen mental health.
  • An analysis of 2012-2022 Gallup World Poll data shows that spirituality and various wellbeing outcomes differ broadly at the global level.
  • The report also poses the question of how workplaces might incorporate elements of spirituality into employee wellbeing programs, given the U.S.
  • "Faith and spirituality need to be an integral part of any organization's Diversity, Equity, and Inclusion efforts."